Rimonci Capital
Overview
Rimonci Capital was established in 2016. The primary focus of the fund is to achieve the vision of “For better vision and insight” through globally exploring, incubating and investing in disruptive te…
Investment Focus
- Innovative technology solutions
- Strong management teams
- Scalable business models
- Potential for significant market impact
- Alignment with Rimonci Capital's strategic focus areas
Portfolio Companies
Reach Rimonci Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Rimonci Capital
What sectors does Rimonci Capital invest in?
Rimonci Capital invests in Technology, Healthcare, Artificial Intelligence, Digital Health, Pharmaceuticals and Medical Devices, and is based in China. Rimonci Capital is listed as a venture capital in the ConnectSafely investor database.
What stage does Rimonci Capital invest at?
Rimonci Capital backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Rimonci Capital invest in?
Rimonci Capital invests across United States, United Kingdom, Canada, Hong Kong, Japan and Australia.
What companies has Rimonci Capital invested in?
Rimonci Capital's portfolio includes 6over6, TECLens, Belkin Vision, Laclarée, EyeYon and NovaSight.
How do I contact Rimonci Capital?
Rimonci Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
